Panacea Life Sciences Holdings, Inc.

PLSH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Feb 12, 2019 CURRENT REPORT
DEF 14C Feb 5, 2019 DEFINITIVE INFORMATION STATEMENT
D Jan 29, 2019
8-K Jan 29, 2019 CURRENT REPORT
8-K Jan 25, 2019 CURRENT REPORT
8-K Jan 24, 2019 CURRENT REPORT
3 Jan 23, 2019
SC 13D Jan 22, 2019 SCHEDULE 13D
8-K/A Jan 22, 2019 AMENDMENT NO. 1
PRE 14C Jan 22, 2019 PRELIMINARY INFORMATION STATEMENT
8-K Jan 18, 2019 CURRENT REPORT
3 Jan 17, 2019
3 Jan 17, 2019
8-K Jan 14, 2019 CURRENT REPORT
S-8 Dec 26, 2018 S-8
SC 13D Dec 21, 2018 SCHEDULE 13D
SC 13D Dec 21, 2018 SCHEDULE 13D
8-K Dec 21, 2018 CURRENT REPORT
10-Q Nov 14, 2018 QUARTERLY REPORT
8-K Nov 7, 2018 CURRENT REPORT
8-K Oct 12, 2018 CURRENT REPORT
4/A Sep 14, 2018
DEF 14C Sep 14, 2018 DEFINITIVE SCHEDULE 14C
4 Sep 14, 2018
8-K Sep 14, 2018 CURRENT REPORT
← Newer Page 9 of 13 · 316 filings Older →